Share This Article:

Novel Engineered Human Fluorescent Osteoblasts for Scaffolds Bioassays

Abstract Full-Text HTML Download Download as PDF (Size:1089KB) PP. 1-6
DOI: 10.4236/jbnb.2010.11001    4,558 Downloads   7,860 Views   Citations

ABSTRACT

Many cellular models have been used to investigate bone substitutes including coralderived hydroxylapatite (HA). The aim of this study was to verify whether a new cellular model represented by Saos-eGFP cells can be used to test biomaterials by in vitro assays. SaoseGFP cells which express the enhanced Green Fluorescent Protein (eGFP), were derived from the osteoblast-like cell line Saos-2. To this purpose Saos-eGFP cells were employed to investigate the in-vitro bioactivity of a well characterized coral-derived HA biomaterial, in block and granule forms. This engineered cell line, by evaluating the emitted fluorescence, allowed us to assay (i) cell adhesion, (ii) cell proliferation and (iii) colony capability. Electron microscopy analysis was employed to evaluate the (iv) morphology of cells seeded on the biomaterial surface. (v) Histological analysis of the bone grown after scaffold implantation was carried out in specimens from two clinical cases. Saos-eGFP cells indicate, as established before, that the coralline-HA biomaterials has a good in vitro cytocompatibility when tested with human osteoblast-like cells. Some differences in proliferation activity was detected for the two different forms assayed. Cytocompatibility data from in vitro analyses were confirmed by in vivo behaviour of biomaterials. Our tests suggest that the engineered cell line Saos-eGFP represents a suitable in vitro mode for studying the biocompatibility, the cell adhesion, spreading and proliferation on biomaterials developed for clinical applications. The main advantages of this cellular model are (i) less time consuming and (ii) a reduced cost of the experiments.

Conflicts of Interest

The authors declare no conflicts of interest.

Cite this paper

K. Campioni, C. Morelli, A. D. Agostino, L. Trevisiol, P. Nocini, M. Manfrini and M. Tognon, "Novel Engineered Human Fluorescent Osteoblasts for Scaffolds Bioassays," Journal of Biomaterials and Nanobiotechnology, Vol. 1 No. 1, 2010, pp. 1-6. doi: 10.4236/jbnb.2010.11001.

References

[1] J. A. Hubbell, “Bioactive Biomaterials,” Current Opinion in Biotechnology, Vol. 10, No. 2, 1999, pp. 123-129.
[2] L. F. Reichardt, “Introduction: Extracellular Matrix Molecules. Guidebook to the Extracellular Matrix, Anchor, and Adhesion Proteins,” Oxford University Press, New York, 1999, p. 335.
[3] E. H. Danen and A. Sonnenberg, “Integrins in Regulation of Tissue Development and Function,” The Journal of Pathology, Vol. 201, No. 4, 2003, pp. 632-641.
[4] M. M. Sandberg and H. T. Aro, “Gene Expression during Bone Repair,” Clinical Orthopaedics and Related Research, Vol. 289, 1993, pp. 292-312.
[5] T. T. Kon and J. Cho, “Expression of Osteoprotegerin, Receptor Activator of NF-kappaB Ligand (Osteoprotegerin Ligand) and Related Proinflammatory Cytokines During Fracture Healing,” Journal of Bone and Mineral Research, Vol. 16, No. 6, 2001, pp. 1004-1014.
[6] J. R. Lieberman and A. Daluiski, “The Role of Growth Factors in the Repair of Bone. Biology and Clinical Applications.” Journal of Bone Joint and Surgery, Vol. 84, No. A-6, 2002, pp. 1032-1044.
[7] D. M. Roy and S. K. Linnehan, “Hydroxyapatite Formed from Coral Skeletal Carbonate by Hydrothermal Exchange,” Nature, Vol. 247, No. 438, 1974, pp. 220-222.
[8] A. R. Vaccaro, K. Chiba, et al., “Bone Grafting Alternatives in Spinal Surgery,” The Spine Journal, Vol. 2, No. 3, 2002, pp. 206-215.
[9] O. Shamsuria, A. S. Fadilah, A. B. Asiah, M. R. Rodiah, A. H. Suzina and A. R. Samsudin “In Vitro Cytotoxicity Evaluation of Biomaterials on Human Osteoblast Cells CRL-1543; Hydroxyapatite, Natural Coral and Polyhydroxybutarate,” Medical Journal of Malaysia, Vol. 59, Suppl. B, 2004, pp. 174-175.
[10] M. Barron, L. Franklin, J. Woodall Jr., S. Wingerter, H. Benghuzzi and M. Tucci, “Comparison of Osteoconductive Materials on MG63 Osteoblast Cell Function,” Biomedical Sciences Instrumentation, Vol. 43, 2007, pp. 248-253.
[11] J. C. Fricain, J. Alouf, et al., “Cytocompatibility Study of Organic Matrix Extracted from Caribbean Coral Porites Astroides,” Biomaterials, Vol. 23, No. 3, 2002, pp. 673-679.
[12] C. Morelli, G. Barbanti-Brodano, et al., “Cell Morphology, Markers, Spreading, and Proliferation on Orthopaedic Biomaterials. An Innovative Cellular Model for the In Vitro Study,” The Journal of Biomedical Materials Research, Vol. 83, No. 1, 2007, pp. 178-183.
[13] M. Tognon, C. Morelli, et al., “A Novel Genetically Engineered Human Osteoblasts for the in Vitro Study of Biomaterials,” In: N. Ashammakhi, R. Reis and F. Chiellini, Eds., Topics in Tissue Engineering, 2008, pp. 1-13.
[14] C.T. Begley, M. J. Doherty, D. P. Hankey and D. J. Wilson, “The Culture of Human Osteoblasts upon Bone Graft Substitutes,” Bone, Vol. 14, No. 4, 1993, pp. 661-666.

  
comments powered by Disqus

Copyright © 2018 by authors and Scientific Research Publishing Inc.

Creative Commons License

This work and the related PDF file are licensed under a Creative Commons Attribution 4.0 International License.